Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06210009 · ClinicalTrials.gov registry record · NA

Effect of a DASH-Style Diet on Urinary Risk Factors for Kidney Stone Disease

A NA study of Kidney Stone, sponsored by University of Alabama at Birmingham.

Recruiting
Registry status
NA
Development phase
48
Enrollment target
1
Study location

NCT06210009: Recruiting NA study of Kidney Stone, sponsored by University of Alabama at Birmingham.

NCT06210009 is a NA study of Kidney Stone that is actively recruiting participants, run by University of Alabama at Birmingham. The registered enrollment target is 48 participants, below the 191-participant average among 28 other Kidney Stone trials with a reported enrollment target (75% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06210009, a NA study of Kidney Stone, is actively recruiting participants, sponsored by University of Alabama at Birmingham.

RECRUITING
Registry status
NA
Development phase
48 participants
Enrollment target
1
Study location

Study Summary

The true capacity for a healthy diet to improve urinary stone risk factors is not well-defined. The objective of this study is to measure the effect of adopting a healthy dietary pattern on kidney stone disease (KSD) risk. The working hypothesis is that a Dietary Approaches to Stop Hypertension (DASH)-style diet will improve 24-hour urine stone risk parameters. The approach to testing this hypothesis will be to randomize participants with KSD to a standardized DASH-style vs. Western-style diet for one week. The Bionutrition Unit of the Center for Clinical and Translational Science will provide all meals to participants. The rationale for this study is that by measuring the effect of a DASH-style diet on urinary stone risk parameters, a benchmark for future real-world, implementation studies will be established. Based on available evidence, this will be the first controlled diet study to assess the DASH dietary pattern for improving urinary stone risk parameters.

Primary Outcome

Supersaturation of calcium oxalate is an index reflecting the propensity for the formation and growth of the most common stone type (calcium oxalate), which is calculated using excretion rates including urinary volume, calcium, citrate, and oxalate.

Conditions Studied

Interventions

  • OTHER DASH-Style Diet
  • OTHER Western-Style Diet

Study Locations (1)

Alabama

  • University of Alabama at Birmingham - Birmingham

Trial Details

FieldValue
Enrollment Target 48 participants
Start Date 2025-01-06
Est. Completion 2027-08-31
Phase NA
University of Alabama at Birmingham

1,160 total trials

What NCT06210009 shows while recruiting

NCT06210009 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 48 participants, a relatively small participant target, below the 191-participant average among 28 other Kidney Stone trials with a reported enrollment target (75% lower).

The record links to 1 condition, with Kidney Stone appearing as the primary indexed condition, and to 2 interventions - of which DASH-Style Diet is the first listed.

NCT06210009 reports a single indexed study location in Alabama.

Frequently Asked Questions

What is clinical trial NCT06210009 about?

NCT06210009 is a clinical study titled "Effect of a DASH-Style Diet on Urinary Risk Factors for Kidney Stone Disease". The true capacity for a healthy diet to improve urinary stone risk factors is not well-defined. The objective of this study is to measure the effect of adopting a healthy dietary pattern on kidney stone disease (KSD) risk. The working hypothesis is that a Dietary Approaches to Stop Hypertension (DAS...

What is the current status of trial NCT06210009?

This trial is currently recruiting. It is a NA study. The enrollment target is 48 participants. The study started on 2025-01-06. Estimated completion is 2027-08-31.

What conditions does trial NCT06210009 study?

This clinical trial studies the following conditions: Kidney Stone.

What interventions are being tested in trial NCT06210009?

The interventions under investigation include: DASH-Style Diet (OTHER), Western-Style Diet (OTHER).

Who is sponsoring clinical trial NCT06210009?

This trial is sponsored by University of Alabama at Birmingham, which has 1,160 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06210009 being conducted?

This trial has 1 study location across Alabama. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Kidney Stone

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT06210009's enrollment target sits among peer trials

48 17th of 28 higher than 12 of 28 other Kidney Stone trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Kidney Stone trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01765777 · 48 participants · NA

    Efficacy of Osteopathic Manipulative Medicine (OMM) and Phototherapy for Patients With Chronic Lower Back Pain

  • NCT03073343 · 48 participants · NA

    A Prospective, Randomized, Open Label Trial of Two Doses of Oral Betaine

  • NCT03431064 · 48 participants

    Lung Recruitment Maneuver as a Potential Predictor of Fluid Responsiveness in Mechanically Ventilated Pediatric Patients

  • NCT03514602 · 48 participants · NA

    Maternal Smoking Cessation and Pediatric Obesity Prevention

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06210009, the US trial registry maintained by the National Library of Medicine. NCT06210009 (small enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.